Immunosuppresion-resistant, tumor-specific T cells as a therapeutic strategy against established tumors – a preclinical study
Laufzeit: 01.01.2023 - 31.12.2025
imported
Kurzfassung
This project investigates if manipulating specific intracellular pathways from T cells could alter the profiles of immunosuppressive regulatory T cells into pro-inflammatory cells that can work together with anti-tumor effector T cells towards a more efficient and synergistic anti-tumor response.